| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Janusz Rak | Q67256958 |
| P2093 | author name string | Shilpa Chennakrishnaiah | |
| Saro Aprikian | |||
| Thupten Tsering | |||
| P2860 | cites work | Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases | Q90700144 |
| Genomic evolution of cancer models: perils and opportunities | Q90712068 | ||
| Liquid biopsy and minimal residual disease - latest advances and implications for cure | Q91845060 | ||
| Oncogenes and Clotting Factors: The Emerging Role of Tumor Cell Genome and Epigenome in Cancer-Associated Thrombosis | Q92080263 | ||
| Tumor-educated platelets | Q92127057 | ||
| Reassessment of Exosome Composition | Q92878002 | ||
| Mapping Subpopulations of Cancer Cell-Derived Extracellular Vesicles and Particles by Nano-Flow Cytometry | Q93012710 | ||
| Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences | Q21147057 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Size matters in nanoscale communication | Q87865962 | ||
| Blood-based biomarkers for the diagnosis and monitoring of gliomas | Q88627964 | ||
| Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles | Q89415996 | ||
| Characterization of single microvesicles in plasma from glioblastoma patients | Q90610949 | ||
| Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
| Routes and mechanisms of extracellular vesicle uptake | Q27023027 | ||
| Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes | Q27317206 | ||
| Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
| Double-stranded DNA in exosomes: a novel biomarker in cancer detection | Q28237711 | ||
| Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma | Q28261810 | ||
| Autophagy mediates degradation of nuclear lamina | Q28269326 | ||
| Cancer genes and the pathways they control | Q28275089 | ||
| Circulating mutant DNA to assess tumor dynamics | Q28289337 | ||
| Membrane vesicles as conveyors of immune responses | Q29547765 | ||
| The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Q29547915 | ||
| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups | Q29614700 | ||
| Ceramide triggers budding of exosome vesicles into multivesicular endosomes | Q29616811 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Directional cell movement through tissues is controlled by exosome secretion | Q30650966 | ||
| Platelet-associated PF-4 as a biomarker of early tumor growth | Q33301427 | ||
| Stromal gene expression predicts clinical outcome in breast cancer | Q33330931 | ||
| Exosomes maintain cellular homeostasis by excreting harmful DNA from cells | Q33716401 | ||
| The fate and lifespan of human monocyte subsets in steady state and systemic inflammation | Q33886544 | ||
| Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer | Q34039531 | ||
| Neutrophil kinetics in health and disease. | Q34092240 | ||
| Cell-free nucleic acids as biomarkers in cancer patients | Q34184393 | ||
| Liquid biopsy: monitoring cancer-genetics in the blood | Q34356149 | ||
| Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma | Q34391844 | ||
| The role of leukocytes in thrombosis. | Q34532246 | ||
| Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways | Q34820412 | ||
| Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling | Q35005587 | ||
| ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles | Q35148002 | ||
| Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin | Q35752935 | ||
| Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer | Q36015233 | ||
| Exosomes biological significance: A concise review | Q36400139 | ||
| Tumour exosome integrins determine organotropic metastasis. | Q36677568 | ||
| Measurement of red cell lifespan and aging | Q36917842 | ||
| Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR | Q37129376 | ||
| Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. | Q52507969 | ||
| The Platelet Lifeline to Cancer: Challenges and Opportunities. | Q52719266 | ||
| Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. | Q55115778 | ||
| Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. | Q55466614 | ||
| Extracellular vesicles in cancer - implications for future improvements in cancer care | Q57143872 | ||
| Current and future perspectives of liquid biopsies in genomics-driven oncology | Q58586693 | ||
| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines | Q60326168 | ||
| The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells | Q62644136 | ||
| Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid | Q62745703 | ||
| The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research | Q64111771 | ||
| Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis | Q80998934 | ||
| Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus | Q84756189 | ||
| Proteomic and immunologic analyses of brain tumor exosomes | Q37159215 | ||
| Epidemiology of cancer-related venous thromboembolism | Q37242472 | ||
| The perivascular niche regulates breast tumour dormancy. | Q37305997 | ||
| Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations | Q37628002 | ||
| Epidemiology of cancer-associated venous thrombosis | Q38125997 | ||
| Cancer-associated pathways and biomarkers of venous thrombosis | Q38642557 | ||
| Advances in the molecular genetics of gliomas - implications for classification and therapy | Q38777058 | ||
| Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake | Q38800211 | ||
| PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells. | Q38835020 | ||
| Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content | Q38843843 | ||
| Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes | Q38967191 | ||
| Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells | Q38969334 | ||
| Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism. | Q39028469 | ||
| Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation | Q39080295 | ||
| Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake | Q39095592 | ||
| Liquid Biopsies, What We Do Not Know (Yet). | Q39135342 | ||
| Liquid biopsies come of age: towards implementation of circulating tumour DNA. | Q39149201 | ||
| Integrating liquid biopsies into the management of cancer | Q39157824 | ||
| Prospects for combining targeted and conventional cancer therapy with immunotherapy | Q39198154 | ||
| Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. | Q39222362 | ||
| Mutant IDH1 and thrombosis in gliomas. | Q39355644 | ||
| Clonal evolution of glioblastoma under therapy. | Q39704836 | ||
| Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. | Q39860485 | ||
| Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation | Q39945610 | ||
| Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis | Q40502054 | ||
| Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment. | Q40757835 | ||
| Mechanisms and Regulation of Extracellular DNA Release and Its Biological Roles in Microbial Communities | Q41126069 | ||
| Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer | Q41548598 | ||
| Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras | Q42330185 | ||
| Flow Cytometry of Extracellular Vesicles: Potential, Pitfalls, and Prospects | Q43636670 | ||
| Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype | Q44444427 | ||
| Soluble carcinoembryonic antigen activates endothelial cells and tumor angiogenesis | Q46084302 | ||
| Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients | Q46246365 | ||
| Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer | Q47101598 | ||
| Detection and localization of surgically resectable cancers with a multi-analyte blood test. | Q48216212 | ||
| Circulating tumor cell count and thrombosis in metastatic breast cancer. | Q48286587 | ||
| Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA. | Q48512022 | ||
| Blood platelets contain tumor-derived RNA biomarkers | Q48954046 | ||
| Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. | Q49829985 | ||
| Shedding light on the cell biology of extracellular vesicles | Q50018560 | ||
| Impact of oncogenic pathways on evasion of antitumour immune responses. | Q50076984 | ||
| Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization | Q50089383 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1608 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Leukobiopsy - A Possible New Liquid Biopsy Platform for Detecting Oncogenic Mutations | |
| P478 | volume | 10 |
Search more.